Arbutus Biopharma
ABUS
ABUS
50 hedge funds and large institutions have $133M invested in Arbutus Biopharma in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 5 closing their positions.
Holders
50
Holders Change
-3
Holders Change %
-5.66%
% of All Funds
1.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
18
Reduced
16
Closed
5
Calls
$483K
Puts
$189K
Net Calls
+$294K
Net Calls Change
+$363K
Top Buyers
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
AWG
2
Alpha Wave Global
New York
|
$0 |
3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$895K |
4 |
4
Goldman Sachs
New York
|
$330K |
5 |
5
Jennison Associates
New York
|
$0 |